CSN2
gene geneOn this page
Summary
CSN2 (casein beta, HGNC:2447) is a protein-coding gene on chromosome 4q13.3, encoding Beta-casein (P05814). Important role in determination of the surface properties of the casein micelles.
This gene is a member of the beta casein family. There are two types of casein protein, beta (encoded by this gene) and kappa, both of which are secreted in human milk. Beta casein is the principal protein in human milk and the primary source of essential amino acids for a suckling infant. Beta and kappa casein proteins acting together form spherical micelles which bind within them important dietary minerals, such as calcium and phosphorous. In addition, the C-terminal 14 aa of the protein has antimicrobial activity, especially in preterm milk, displaying antibacterial activity against S. aureus and Y. enterocolitica. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 1447 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.17 (unconstrained)
- MANE Select transcript:
NM_001891
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2447 |
| Approved symbol | CSN2 |
| Name | casein beta |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000135222 |
| Ensembl biotype | protein_coding |
| OMIM | 115460 |
| Entrez | 1447 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
MANE Select: ENST00000353151
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000353151
RefSeq mRNA: 3 — MANE Select: NM_001891
NM_001302770, NM_001385731, NM_001891
CCDS: CCDS3532
Canonical transcript exons
ENST00000353151 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000865215 | 69958909 | 69958953 |
| ENSE00001024573 | 69960945 | 69961007 |
| ENSE00001024574 | 69960053 | 69960079 |
| ENSE00001024575 | 69959049 | 69959069 |
| ENSE00001024576 | 69957274 | 69957804 |
| ENSE00001076574 | 69956314 | 69956355 |
| ENSE00001395695 | 69955256 | 69955592 |
| ENSE00003935595 | 69965681 | 69965728 |
Expression profiles
Bgee: expression breadth broad, 42 present calls, max score 98.48.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, tonsil, saliva-secreting gland, minor salivary gland, olfactory segment of nasal mucosa.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CSN2 is not an eGene in any GTEx v10 tissue: no tissue shows a variant significantly associated with its expression or splicing (q < 0.05).
Top tissues by expression
showing 100 of 112 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 98.48 | gold quality |
| tonsil | UBERON:0002372 | 48.77 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 46.44 | gold quality |
| minor salivary gland | UBERON:0001830 | 43.70 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 42.08 | gold quality |
| sural nerve | UBERON:0015488 | 38.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 37.34 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 34.85 | gold quality |
| placenta | UBERON:0001987 | 33.81 | silver quality |
| muscle tissue | UBERON:0002385 | 33.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| urinary bladder | UBERON:0001255 | 30.10 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| pancreas | UBERON:0001264 | 28.45 | gold quality |
| monocyte | CL:0000576 | 28.16 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 28.11 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| muscle of leg | UBERON:0001383 | 27.00 | silver quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gastrocnemius | UBERON:0001388 | 26.25 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 26.04 | silver quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 25.95 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| frontal cortex | UBERON:0001870 | 24.27 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| Ammon’s horn | UBERON:0001954 | 24.02 | silver quality |
| kidney | UBERON:0002113 | 23.93 | gold quality |
| cortex of kidney | UBERON:0001225 | 23.81 | gold quality |
| stomach | UBERON:0000945 | 23.29 | silver quality |
| endometrium | UBERON:0001295 | 23.24 | gold quality |
| left uterine tube | UBERON:0001303 | 23.14 | silver quality |
| calcaneal tendon | UBERON:0003701 | 23.08 | gold quality |
| body of stomach | UBERON:0001161 | 22.85 | silver quality |
| heart left ventricle | UBERON:0002084 | 22.77 | silver quality |
| rectum | UBERON:0001052 | 22.68 | gold quality |
| body of pancreas | UBERON:0001150 | 22.60 | silver quality |
| heart | UBERON:0000948 | 22.57 | silver quality |
| hypothalamus | UBERON:0001898 | 22.52 | gold quality |
| right lobe of liver | UBERON:0001114 | 22.36 | gold quality |
| multicellular organism | UBERON:0000468 | 22.28 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 22.15 | gold quality |
| tibial artery | UBERON:0007610 | 22.08 | gold quality |
| popliteal artery | UBERON:0002250 | 22.07 | gold quality |
| small intestine | UBERON:0002108 | 22.05 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 22.04 | gold quality |
| myometrium | UBERON:0001296 | 21.65 | gold quality |
| adenohypophysis | UBERON:0002196 | 21.65 | gold quality |
| adrenal tissue | UBERON:0018303 | 21.63 | gold quality |
| right atrium auricular region | UBERON:0006631 | 21.61 | silver quality |
| fundus of stomach | UBERON:0001160 | 21.52 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 21.10 | gold quality |
| lower esophagus | UBERON:0013473 | 20.99 | gold quality |
| brain | UBERON:0000955 | 20.97 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 20.92 | gold quality |
| ascending aorta | UBERON:0001496 | 20.88 | silver quality |
| temporal lobe | UBERON:0001871 | 20.84 | silver quality |
| thoracic aorta | UBERON:0001515 | 20.70 | silver quality |
| amygdala | UBERON:0001876 | 20.65 | silver quality |
| granulocyte | CL:0000094 | 20.63 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 20.43 | silver quality |
| testis | UBERON:0000473 | 20.38 | gold quality |
| body of uterus | UBERON:0009853 | 20.35 | silver quality |
| substantia nigra | UBERON:0002038 | 20.34 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 20.29 | silver quality |
| apex of heart | UBERON:0002098 | 20.28 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 20.26 | silver quality |
| ectocervix | UBERON:0012249 | 20.18 | gold quality |
| right adrenal gland | UBERON:0001233 | 20.16 | gold quality |
| pituitary gland | UBERON:0000007 | 20.00 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 19.91 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 19.64 | gold quality |
| omental fat pad | UBERON:0010414 | 19.62 | silver quality |
| skin of abdomen | UBERON:0001416 | 19.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 19.53 | gold quality |
| zone of skin | UBERON:0000014 | 19.50 | gold quality |
| thyroid gland | UBERON:0002046 | 19.41 | gold quality |
| corpus callosum | UBERON:0002336 | 19.39 | gold quality |
| right coronary artery | UBERON:0001625 | 19.38 | gold quality |
| skin of leg | UBERON:0001511 | 19.13 | gold quality |
| left coronary artery | UBERON:0001626 | 19.00 | gold quality |
| cerebellum | UBERON:0002037 | 18.97 | gold quality |
| putamen | UBERON:0001874 | 18.92 | gold quality |
| right testis | UBERON:0004534 | 18.87 | gold quality |
| nucleus accumbens | UBERON:0001882 | 18.85 | gold quality |
| cerebellar cortex | UBERON:0002129 | 18.85 | gold quality |
| spleen | UBERON:0002106 | 18.64 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 18.60 | gold quality |
| prostate gland | UBERON:0002367 | 18.53 | gold quality |
| right ovary | UBERON:0002118 | 18.39 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10855 | yes | 109800.98 |
| E-MTAB-10885 | yes | 94569.26 |
| E-MTAB-9841 | yes | 75448.36 |
| E-ANND-3 | no | 2.29 |
HPA expression
RNA tissue specificity: Tissue enriched
6 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Breast | tissue | 538.2 | low |
| Thymus | tissue | 5.2 | |
| Salivary gland | tissue | 2.5 | not detected |
| Seminal vesicle | tissue | 0.4 | not detected |
| Smooth muscle | tissue | 0.1 | not detected |
| Lactating breast | tissue | -1.0 | high |
Brain sub-regions (HPA Brain Atlas): detected in 102; highest nTPM — Corpus callosum, splenium (white matter) (80.5), Corpus callosum, genu (white matter) (79.8), Cerebellar white matter (75.7), Lateral funiculus (white matter) (75.6), Anterior funiculus (white matter) (71.0).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): BCL6, CEBPA, CEBPB, CEBPG, DDIT3, ESR1, ESR2, FOS, HNF4A, ID4, MYC, NCOA1, NFKB1, NFKB, NR0B2, NR3C1, NR3C2, NRG1, PGR, POU2F1, POU2F2, PPARA, PPARG, RELA, RUNX2, SMAD2, SMAD3, SMAD4, STAT1, STAT3, STAT5A, STAT5B, STAT6, TP53, TP63, TSC22D3, YY1, ZNF335
miRNA regulators (miRDB)
Targeting CSN2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 48 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-6758-3P | 99.57 | 67.55 | 1078 |
| HSA-MIR-190A-5P | 99.54 | 71.45 | 933 |
Functional genomics
gnomAD constraint: pLI 0.00146, LOEUF 1.17, missense Z -1.06 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000353151 — one region, missense o/e 1.26.
Literature-anchored findings (GeneRIF, showing 9)
- New functions of lactoferrin and beta-casein in mammalian milk as cysteine protease inhibitors. They might play a role in antiseptic and antiinfectious functions due to cysteine protease inhibition of bacteria and viruses. (PMID:12788072)
- The RCM-kappa does form concentration-dependent micelles. Also, beta-CN phosphorylation level influences micelle formation. Complexes were low-temperature reversible and RCM-kappa fibrils were seen. (PMID:16947075)
- a negative cross talk between PR and Stat5a/GR may contribute to the physiological role of progesterone to repress lactogenic hormone induction of the beta-casein gene (PMID:16973758)
- derivatives of peptide fragment (54-59) exhibit immunosuppressant activity (PMID:19463972)
- Milk congestion gives rise to higher levels of beta-casomorphin-8 in milk and plasma than in lactating women without problems. (PMID:24189037)
- The acidic fragment of human Abeta (Abeta1-11) and a phosphorylated fragment of beta-Casein induced tau fibrillization in vitro. (PMID:24364857)
- Exogenous 5-HT decreased beta-casein expression in MCF-12A human mammary epithelial cells and was responsible for inhibiting phosphorylation of STAT5, resulting in a decline in lactational function. (PMID:25087955)
- Data suggest that neurogenesis in neuronal stem cells is differentially affected by human and bovine beta-casein-derived opioid peptides BCM7 and BCM9; such neurogenic changes are accompanied by changes in glutathione/glutathione disulfide ratio and in S-adenosylmethionine/S-adenosylhomocysteine ratio, indicative of changes in redox and methylation states (including DNA methylation). (PMID:27611101)
- The PDC213 peptide derived from CSN2 displays antimicrobial activity against S. aureus and Y. enterocolitica. (PMID:28093229)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Csn2 | ENSMUSG00000063157 |
| rattus_norvegicus | Csn2 | ENSRNOG00000039326 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:88541) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 2 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| maternal effect | 1 |
| abnormal milk composition | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Ovis aries | P11839 | 99.1% | Diamond |
| Capra hircus | P33048 | 99.1% | Diamond |
| Bos taurus | P02666 | 97.3% | Diamond |
| Bubalus bubalis | Q9TSI0 | 97.3% | Diamond |
| Equus asinus | P86273 | 84.5% | Diamond |
| Equus caballus | Q9GKK3 | 84.5% | Diamond |
| Camelus dromedarius | Q9TVD0 | 71.9% | Diamond |
| Sus scrofa | P39037 | 55.1% | Diamond |
| Oryctolagus cuniculus | P09116 | 53.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CSN1S1 | protein-coding | 1446 |
| HTN3 | protein-coding | 3347 |
| STATH | protein-coding | 6779 |
| SULT1B1 | protein-coding | 27284 |
| SULT1E1 | protein-coding | 6783 |
| HTN1 | protein-coding | 3346 |
Protein
Protein identifiers
Beta-casein — P05814 (reviewed: P05814)
All UniProt accessions (2): P05814, W5RWE1
UniProt curated annotations — full annotation on UniProt →
Function. Important role in determination of the surface properties of the casein micelles.
Subcellular location. Secreted.
Tissue specificity. Mammary gland specific. Secreted in milk.
Post-translational modifications. Form 1-P is phosphorylated once; half of the molecules are phosphorylated on Ser-24, half on Ser-25. (Microbial infection) Proteolytically cleaved by H.pylori HtrA.
Similarity. Belongs to the beta-casein family.
RefSeq proteins (3): NP_001289699, NP_001372660, NP_001882* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001588 | Casein | Family |
| IPR016345 | Casein_beta | Family |
| IPR031305 | Casein_CS | Conserved_site |
Pfam: PF00363
UniProt features (19 total): sequence conflict 12, modified residue 5, signal peptide 1, chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P05814-F1 | 60.09 | 0.04 |
Human Protein Atlas
Protein class: Predicted secreted proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH supported
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5)
| Type | Positions |
|---|---|
| Phosphothreonine | 18 |
| Phosphoserine | 21, 23, 24, 25 |
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 5; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
5 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-9927426 | Developmental Lineage of Mammary Gland Alveolar Cells | curated |
| R-HSA-1251985 | Nuclear signaling by ERBB4 | curated |
| R-HSA-162582 | Signal Transduction | — |
| R-HSA-1236394 | Signaling by ERBB4 | — |
| R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | — |
MSigDB gene sets: 109 (showing top):
PID_REG_GR_PATHWAY, GOBP_MONOATOMIC_CATION_TRANSPORT, chr4q13, CATTTCA_MIR203, WTGAAAT_UNKNOWN, GOBP_SECRETION, GOBP_MAMMARY_GLAND_DEVELOPMENT, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GOBP_BODY_FLUID_SECRETION, GATA4_Q3, GOBP_REGULATION_OF_BODY_FLUID_LEVELS, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP, GOBP_LACTATION, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP, GOMF_PEPTIDASE_REGULATOR_ACTIVITY
GO Biological Process (2): calcium ion transport (GO:0006816), lactation (GO:0007595)
GO Molecular Function (4): enzyme inhibitor activity (GO:0004857), cysteine-type endopeptidase inhibitor activity (GO:0004869), calcium ion binding (GO:0005509), protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
4 top-level categories:
| Category | Pathways |
|---|---|
| Signaling by ERBB4 | 1 |
| Developmental Lineages of the Mammary Gland | 1 |
| Signaling by Receptor Tyrosine Kinases | 1 |
| Signal Transduction | 1 |
GO top-level categories
12 GO namespaces:
| Category | Terms |
|---|---|
| metal ion transport | 1 |
| body fluid secretion | 1 |
| mammary gland development | 1 |
| milk ejection reflex | 1 |
| catalytic activity | 1 |
| enzyme regulator activity | 1 |
| molecular function inhibitor activity | 1 |
| cysteine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| metal ion binding | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 2 of 8 annotations. The rest are phylogenetic / computational / electronic (IEA).
2 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| lactation | BP | direct assay |
| cysteine-type endopeptidase inhibitor activity | MF | direct assay |
Protein interactions and networks
STRING
showing 15 of 752 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CSN2 | CSN1S1 | P47710 | 982 |
| CSN2 | CSN3 | P07498 | 972 |
| CSN2 | LALBA | P00709 | 902 |
| CSN2 | PRL | P01236 | 881 |
| CSN2 | PRLR | P16471 | 784 |
| CSN2 | LTF | P02788 | 718 |
| CSN2 | BICD2 | Q8TD16 | 694 |
| CSN2 | NEK9 | Q8TD19 | 674 |
| CSN2 | BTN1A1 | Q13410 | 671 |
| CSN2 | NEK6 | Q9HC98 | 660 |
| CSN2 | STAT5A | P42229 | 654 |
| CSN2 | HTRA1 | Q92743 | 654 |
| CSN2 | NEK7 | Q8TDX7 | 652 |
| CSN2 | INS | P01308 | 644 |
| CSN2 | TPH1 | P17752 | 623 |
IntAct
Human interaction partners of CSN2 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
11 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| FHL2 | physical association | 0.670 | 4 |
| UBQLN2 | physical association | 0.560 | 6 |
| CRYBB3 | association | 0.530 | 2 |
| PPP3CC | association | 0.530 | 1 |
| ACE2 | protein cleavage | 0.440 | 1 |
| FAM20C | phosphorylation reaction | 0.440 | 1 |
| CDC42 | physical association | 0.000 | 1 |
| GRB2 | physical association | 0.000 | 1 |
| NFYC | physical association | 0.000 | 1 |
| RAC1 | physical association | 0.000 | 1 |
| TOLLIP | physical association | 0.000 | 1 |
BioGRID (41 interactions; top human partners by supporting records): PLK1 (Biochemical Activity; 3 records), CORO2A (Affinity Capture-MS; 2 records), CSNK2A1 (Biochemical Activity; 2 records), FHL2 (Two-hybrid; 2 records), HTRA2 (Biochemical Activity; 2 records), PPP3CC (Affinity Capture-MS; 2 records), ARHGAP36 (Affinity Capture-MS), ARRB1 (Affinity Capture-MS), ARRB2 (Affinity Capture-MS), AURKA (Biochemical Activity), CDC42 (Two-hybrid), CDK1 (Biochemical Activity), CHPF (Affinity Capture-MS), COPS7A (Affinity Capture-MS), CRYBB3 (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for CSN2: 45 ClinVar records (0 pathogenic / likely pathogenic).
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 8 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 18 predictions of 510):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 4:69958894 | donor_gain | 1.0000 | |
| 4:69960947 | donor_gain | 0.9900 | |
| 4:69965679–69965680 | donor_loss | 0.9900 | 4 |
| 4:69956497 | acceptor_gain | 0.9700 | |
| 4:69957638 | donor_gain | 0.9700 | |
| 4:69957651 | donor_gain | 0.9700 | |
| 4:69958907–69958908 | donor_loss | 0.9700 | 6 |
| 4:69961016 | acceptor_gain | 0.9700 | |
| 4:69956499 | acceptor_gain | 0.9600 | |
| 4:69958906 | donor_loss | 0.9600 |
AlphaMissense
47 missense substitutions predicted likely pathogenic (of 1,463 scored), across 19 residues. Top 19 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| K2 | 4 | 0.718 | 0.770 |
| C8 | 3 | 0.871 | 0.981 |
| A15 | 3 | 0.801 | 0.832 |
| I5 | 3 | 0.798 | 0.827 |
| L6 | 3 | 0.786 | 0.819 |
| F68 | 3 | 0.773 | 0.773 |
| L12 | 3 | 0.761 | 0.880 |
| L9 | 3 | 0.728 | 0.876 |
| L4 | 3 | 0.712 | 0.730 |
| M115 | 3 | 0.587 | 0.587 |
| F76 | 3 | 0.572 | 0.572 |
| A13 | 2 | 0.837 | 0.840 |
| A11 | 2 | 0.825 | 0.895 |
| A7 | 2 | 0.804 | 0.900 |
| E17 | 2 | 0.664 | 0.716 |
| N80 | 2 | 0.579 | 0.579 |
| V10 | 1 | 0.839 | 0.839 |
| L14 | 1 | 0.803 | 0.803 |
| V3 | 1 | 0.682 | 0.682 |
HPA cancer prognostics
RNA cancer specificity: Cancer enriched (Breast Invasive Carcinoma)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
3 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 8.53e-08 |
| Kidney Renal Clear Cell Carcinoma (validation) | favorable | 4.81e-05 |
| Pancreatic Adenocarcinoma (TCGA) | unfavorable | 0.000435 |
Disease associations
OMIM: gene MIM:115460 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| linalool | increases expression | 1 |
| Rosiglitazone | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.